Risk of hospitalization because of aseptic meningitis after measles- mumps-rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) project

Pediatric Infectious Disease Journal

Volumn 16, Issue 5, 1997, Pages 500-503

  Black, Steven ^a,f   Shinefield, Henry ^a   Ray, Paula ^a   Lewis, Edwin ^a   Chen, Robert ^b   Glasser, John ^b   Hadler, Steven ^b   Hardy, Janet ^b   Rhodes, Phil ^b   Swint, Emmet ^b   Davis, Robert ^c   Thompson, Robert ^c   Mullooly, John ^a   Marcy, Michael ^a   Vadheim, Connie ^d   Ward, Joel ^d   Rastogi, Suresh ^e   Wise, Robert ^e  

^a KAISER PERMANENTE   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^f KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

aseptic meningitis; measles mumps rubella; Mumps

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; ASEPTIC MENINGITIS; CHILD; CONTROLLED STUDY; DRUG SAFETY; DRUG SCREENING; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MEASLES VACCINATION; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, ASEPTIC; MUMPS VACCINE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; RUBELLA VACCINE; STATISTICS; UNITED STATES; VACCINES, COMBINED;

EID: 0030972868     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199705000-00009     Document Type: Article

References (11)

1. Cherry JD, Shields WD. Encephalitis and meningoencephalitis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. Philadelphia: Saunders, 1987:484-96.
2. Centers for Disease Control. Mumps: United States 1980-1993. MMWR 1995;44:55.
3. Colville A, Pugh S. Mumps meningitis and measles, mumps, rubella vaccine. Lancet 1992;340:786.
4. Farrington, P. Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/ tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995;345:567.
5. Sugiura A, Lyamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 1991;10:209-13.
6. Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps, rubella vaccine. Pediatr Infect Dis J 1991;10:204-9.
7. Miller E, Goldacre M, Pugh S, et al. Risk of aseptic meningitis after measles, mumps, rubella vaccine in UK children. Lancet 1993;341:979.
8. Wassilak SG, Glasser JW, Chen RT, Hadler SC, et al. Utility of Large Linked Databases in Vaccine Safety, particularly in distinguishing independent and synergistic effects. Ann NY Acad Sci 1995;754:377-82.
9. Schlesselman J. Case control studies: design, conduct, and analyses. New York: Oxford University Press, 1982:227-90.
10. SAS Release 6.09. Cary, NC: SAS Institute, Inc.
11. Institute of Medicine. Adverse events associated with childhood vaccines. Washington, DC: National Academy Press, 1994:130.